- Aurinia Pharma ( NASDAQ: AUPH ) is scheduled to announce Q4 earnings results on Tuesday, February 28th, before market open.
- The consensus EPS Estimate is -$0.27 (vs. -$0.25 last year) and the consensus Revenue Estimate is $28.82M (+23.2% Y/Y).
- Over the last 1 year, AUPH has beaten EPS estimates 0% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downward. Revenue estimates have seen 3 upward revisions and 1 downward.
For further details see:
Aurinia Pharma Q4 2022 Earnings Preview